Evidence map›Paper›PMID 42540493›Full record

ArticleiScience2026

A fermented milk drink containing

Yonne Peters, Maria Laura Ferrando, Chengliang Zhou, Rene Te Morsche, Britt van der Leeden, Renske Cremers, Phuc Dat Le, Leander van Dijk, Ruud W M Schrauwen, Adriaan C Tan and 4 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yonne PetersDepartment of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands.
Maria Laura FerrandoHost-Microbe Interactomics, Wageningen University and Research, Wageningen, the Netherlands.
Chengliang ZhouDepartment of Pathology, Radboudumc, Nijmegen, the Netherlands.
Rene Te MorscheDepartment of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands.
Britt van der LeedenDepartment of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands.
Renske CremersDepartment of Pathology, Radboudumc, Nijmegen, the Netherlands.
Phuc Dat LeDepartment of Pathology, Radboudumc, Nijmegen, the Netherlands.
Leander van DijkDepartment of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands.
Ruud W M SchrauwenDepartment of Gastroenterology and Hepatology, Bernhoven Hospital, Uden, the Netherlands.
Adriaan C TanDepartment of Gastroenterology and Hepatology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Rachel S van der PostDepartment of Pathology, Radboudumc, Nijmegen, the Netherlands.
Peter van BaarlenHost-Microbe Interactomics, Wageningen University and Research, Wageningen, the Netherlands.
Peter D SiersemaDepartment of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands.
Annemarie BoleijDepartment of Pathology, Radboudumc, Nijmegen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal adenocarcinoma and its precursor, Barrett's esophagus (BE), are associated with a pro-inflammatory, Gram-negative-dominated esophageal microbiome. In a single-arm pilot study, 23 patients with BE consumed a fermented milk drink containing

Indexed as

Barrett’s esophagusesophageal cancerLactobacillus casei ShirotamicrobiomeYakult

Identifiers

PMID42540493
PMCPMC13426229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.